Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation

Despite the substantial advances in the management of metastatic melanoma with the introduction of immune checkpoint inhibitors (ICI), many patients develop disease progression during treatment with immunotherapy. This has been suggested to be mediated by several mechanisms that contribute to acquir...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Khaddour, Karam, Dowling, Joshua, Huang, Jiayi, Council, Martha, Chen, David, Cornelius, Lynn, Johanns, Tanner, Dahiya, Sonika, Ansstas, George
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2020
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779252/
https://ncbi.nlm.nih.gov/pubmed/33447351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27848
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires